Effects of Autoantibodies Against At1-receptor and Angiotensin II on Refractory Hypertension
廖玉华
魏宇淼
王敏
董继华
王朝晖
苑海涛
1.Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan 430022, P R China2.Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan 430022, P R China3.Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan 430022, P R China4.Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan 430022, P R China5.Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan 430022, P R China6.Institute of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science & Technology,Wuhan 430022, P R China
摘要:Objective The study will explore effects of the autoantibodies against AT1 receptor and angiotensin Ⅱ on the refractory hypertension. Methods Seventy-seven patients (46 men and 31 women) with essential hypertension were divided into groups of refractory hypertension (RH) and hypertension (HT) according to the 1999 WHO -ISH Guidelines for the Management of Hypertension. Forty normotensives (22 men) were recruited as controls.The mean age was 54. 3 ± 13 years old in RH group,53.5±9 years old in HT group and 51.2±11.9years old in normotensives (NT) group. The mean blood pressure was 154.2 ± 9.4/98.4 ± 8.2 mmHg in RH group and 130.1 ±7.6/80.5 ±6.7 mmHg in HT group after combination drug therapy of hypertension for 4 weeks. Blood pressure in NT group was 120. 8 ± 11.7/76. 4 ± 7.2 mmHg. The epitope of the 2nd extracellular loops of AT1 receptor was synthesized and used as antigens to screen the autoantibodies by ELISA. Plasma angiotensin (Ang) Ⅱ were examined by a radioimmunoassay. Results The autoantibodies against AT1 receptor were positive in 18 (46. 15% ) patients with RH, in 4 (10. 5 % ) hypertension and in 3 (7.5 % ) normotensives, P < 0.01. Ang Ⅱwas 57.01 ± 52.63 pmol/L in patients with RH. Both the autoantibodies positive and the Ang Ⅱ increasing were 4 (10. 3 %) cases, both normal were 7 (17.9% ) cases, the autoantibodies positive or Ang Ⅱ in creasing was all of 14 (35.9 % ) cases (χ2 =0. 09,P > 0. 05) There was no relationship between the autoantibodies against AT1 receptor and the angiotensin Ⅱ in refractory hypertension. Conclusion The autoantibodies against AT1 receptor and Ang Ⅱ might be two independent factors in developing of refractory hypertension. The findings suggest that AT1 receptor antagnist used in the treatment of refractory hypertension might have an important value.
机标关键词:
分类号:R54(心脏、血管(循环系)疾病)
论文发表日期:2001-01-01
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:5( 84-88 )
英文信息展开
岭南心血管病杂志(英文版)

岭南心血管病杂志(英文版)

ISSN:1009-8933
年,卷(期):2001,2(2)
所属栏目:CLINICAL INVESTIGATION